Nuances to precision dosing strategies of targeted cancer medicines
Ashley M Hopkins1, Bradley D Menz2, Michael D Wiese3
1College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Abstract:
Selecting the dose of a targeted cancer medicine that is most appropriate for a specific individual is a rational approach to maximize therapeutic outcomes and minimize toxicity. There are many different options for optimizing the dose of targeted cancer medicines and the purpose of this review is to provide a comprehensive comparison of the main options explored in prospective studies. Precision initial dose selection of targeted cancer therapies has been minimally explored to date; however, concentration, toxicity, and therapeutic outcome markers are used to guide on-therapy dose adaption of targeted cancer therapies across several medicines and cancers. While a specific concentration, toxicity, or therapeutic outcome marker commonly dominates an investigated precision on-therapy dose adaption strategy, greater attention to simultaneously account for exposure, toxicity, therapeutic outcomes, disease status, time since treatment initiation and patient preferences are required for optimal patient outcomes. To enable successful implementation of precision dosing strategies for targeted cancer medicines into clinical practice, future prospective studies aiming to develop strategies should consider these elements in their design.
Insights
Optimizing targeted cancer drug doses improves patient outcomes. Future studies should integrate exposure, toxicity, and patient preferences for precision dosing strategies.
Area of Science:
- Pharmacology
- Oncology
- Clinical Pharmacy
Background:
- Individualized dosing of targeted cancer therapies is crucial for maximizing efficacy and minimizing side effects.
- Current precision dosing strategies often focus on single markers like concentration or toxicity.
Purpose of the Study:
- To comprehensively review and compare prospective study options for optimizing targeted cancer medicine doses.
- To highlight the need for integrated approaches in precision dosing.
Main Methods:
- Review of prospective studies on dose optimization strategies for targeted cancer therapies.
- Analysis of commonly used markers for dose adaptation (concentration, toxicity, therapeutic outcomes).
Main Results:
- Precision initial dose selection for targeted therapies is underexplored.
- On-therapy dose adaptation frequently relies on single markers, but a multifactorial approach is needed.
- Optimal outcomes require considering exposure, toxicity, therapeutic results, disease status, treatment duration, and patient preferences.
Conclusions:
- Current precision dosing strategies for targeted cancer medicines are limited.
- Future prospective studies must incorporate multiple factors for robust precision dosing strategies.
- Implementing precision dosing requires a holistic approach considering diverse patient-specific elements.
More Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
Dosage Regimen: Individualization
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Dosage Regimens: Designs and Approaches
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Dose Size and Dosing Frequency: Determination Methods
